
USFDA APPLICATION NUMBER - 21625 / DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
Inactive Ingredients
| Ingredient Name | Hospira, Inc. |
|---|---|
| BUTYLATED HYDROXYANISOLE(REK4960K2U) | |
| BUTYLATED HYDROXYTOLUENE(1P9D0Z171K) | |
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | |
| GENTISIC ACID ETHANOLAMIDE(H4E039OIGX) | |
| POLYSORBATE 20(7T1F30V5YH) | |
| POLYSORBATE 80(6OZP39ZG8H) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | |
| SODIUM HYDROXIDE(55X04QC32I) |